Marksans Pharma Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Marksans Pharma Limited with three other
companies in this sector in India:
Novartis India Limited
sales of 8.08 billion Indian Rupees [US$123.67 million]
of which 81%
Orchid Pharma Ltd
(8.73 billion Indian Rupees [US$133.64 million]
(9.26 billion Indian Rupees [US$141.62 million]
of which 61%
was Pharmaceutical Products).
Marksans Pharma Limited reported sales of 8.93 billion Indian Rupees (US$136.68 million)
March of 2016.
increase of 12.1%
versus 2015, when the company's sales were 7.97 billion Indian Rupees.
Sales at Marksans Pharma Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 193%).